JEFFREY HENLEY - 12 Jun 2025 Form 4 Insider Report for ORACLE CORP (ORCL)

Signature
/s/ Aimee Weast By Aimee Weast, Attorney in Fact for Jeffrey Henley (POA Filed 03/20/19)
Issuer symbol
ORCL
Transactions as of
12 Jun 2025
Transactions value $
-$60,025,016
Form type
4
Filing time
13 Jun 2025, 16:29:29 UTC
Previous filing
18 Apr 2025
Next filing
25 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HENLEY JEFFREY Vice Chairman, Director C/O DELPHI ASSET MGMT CORPORATION, 200 S. VIRGINIA ST., SUITE 625, RENO /s/ Aimee Weast By Aimee Weast, Attorney in Fact for Jeffrey Henley (POA Filed 03/20/19) 13 Jun 2025 0001206100

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORCL Common Stock Options Exercise $16.1M +400K +36.44% $40.36 1.5M 12 Jun 2025 By Trust
transaction ORCL Common Stock Sale -$74.3M -390K -26.06% $190.41 1.11M 12 Jun 2025 By Trust F1, F2
transaction ORCL Common Stock Sale -$1.85M -9.69K -0.88% $191.00 1.1M 12 Jun 2025 By Trust F1
holding ORCL Common Stock 145K 12 Jun 2025 By GRAT
holding ORCL Common Stock 362K 12 Jun 2025 By Henley Community Property Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORCL Stock Option Options Exercise $0 -400K -100% $0.00 0 12 Jun 2025 Common Stock 400K $40.36 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Sale of shares pursuant to Rule 10b5-1 Plan adopted on December 31, 2024.
F2 This transaction was executed in multiple trades at prices ranging from $190.00. to $190.97. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 25% of the shares subject to the option vested annually on each anniversary of the grant date.